Cyclo Therapeutics

Cyclo Therapeutics is a company listed under the stock ticker CYTH (US).

Acquisition, funding and merger involving Cyclo Therapeutics.

• Applied Molecular Transport and Cyclo Therapeutics have announced they will merge  (posted on September 22 2023)..

View the org chart displaying its 14 main executives

Most searched biographies at Cyclo Therapeutics

• Scott Fine, Chief Executive Officer and Director
• Randall Toig, Director
• Vivien Wong, Director

Create your alert
to follow the executive moves at Cyclo Therapeutics.

Cyclo Therapeutics has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Cyclo Therapeutics

• Cyclo Therapeutics News powered by B2i Technologies - SmartWireCyclo Therapeutics News powered by B2i Technologies - SmartWire
• News-old - cyclotherapeutics
• News - cyclotherapeutics
• Newsletters - cyclotherapeutics
• News - cyclotherapeutics

Social media about Cyclo Therapeutics

• Cyclo Therapeutics on Wikipedia, Google News & Yahoo Finance
• Cyclo Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Scott Fine

Call Cyclo Therapeutics at +1 386...

View the org chart

Register to receive your alert

Report an error